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Dr Feigelson and colleagues1 should be commended for
their interesting analysis, “Factors associated with the
frequency of initial total mastectomy.” Although other
studies2,3 have documented an increase in mastectomy
rates to between 35% and 45%, these authors reported
a 16.7% rate of initial mastectomy when more strict
exclusion criteria for study were met. They discussed vari-
ables that might bear on a woman’s decision to choose
mastectomy, including choice of surgeon and preopera-
tive MRI scan, but there is one very important factor
they did not examine: improved mastectomy and recon-
struction have changed the patient’s choice.
Early in my career, I argued that because of improved
mastectomy and reconstructive techniques, the surgical
option offered superior rates of local control and equiva-
lent cosmetic outcomes for noninvasive4 and invasive5
breast cancer. With the further realization that routine
removal of the uninvolved nipple during mastectomy
did not confer a survival benefit to patients with early
breast cancer,6 many studies now demonstrate the
improved esthetic outcomes of nipple-sparing mastec-
tomy.7-9 Reconstruction of a nipple-sparing mastectomy
with a variety of techniques leaves the patient with an
outcome that is cosmetically and oncologically equivalent
to that with lumpectomy, but usually without the need
for radiation therapy.
Women facing mastectomy once were offered a simple
choice: you can have breast preservation with lumpec-
tomy and radiation therapy or you can be mutilated
with a mastectomy. Which do you choose? But now
the question is much different: we can leave your breast
in place, remove the cancer, treat the surrounding tissue
with radiation therapy, and monitor you carefully for
recurrent cancer; or, we can remove your breast, spare
your nipple, and leave you looking almost as good as
you would look with lumpectomy but without the same
risk of recurrent cancer in your breast. A woman’s choice
has changed.
The NIH Consensus Conference of 1991 acknowl-
edged that lumpectomy and radiation therapy was an
equivalent treatment to mastectomy for the majority of960women with early breast cancer. But nipple-sparing
mastectomy with immediate reconstruction changes the
choice. It is now possible for a woman to enjoy the lower
local recurrence rates of mastectomy with an equivalent
cosmetic outcome to those of lumpectomy, with the addi-
tional benefit that they are usually able to avoid radiation
therapy. Therefore, as this choice becomes better under-
stood by doctors and patients alike, we should expect to
see a higher rate of mastectomy for the initial treatment
of breast cancer.
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